The Board has granted the Veteran's claim for service connection for urothelial carcinoma, finding that his exposure to herbicide agents during service is presumed and likely caused his condition.
The deciding factor: The VA medical opinion provided a nexus between the Veteran's in-service exposure to Agent Orange and his diagnosed urothelial carcinoma.
- Claimed conditions
- urothelial carcinoma
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- December 1, 2020
- Citation
- A20017701
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has remanded the case for further development and evaluation of the Veteran's urinary tract disability, including a new VA examination. The issues include determining if the reduction in his urothelial carcinoma rating was proper and whether he should receive continued SMC based on housebound status.
- Remanded (sent back)
The Board remands the claim for a medical opinion addressing whether the Veteran's left eye condition is related to service, as it found that the condition did not preexist service.
- Granted
The Board granted service connection for prostate cancer, related to in-service exposures at Camp Lejeune.
- Granted
The Veteran is granted an effective date of August 10, 2022, for the grant of service connection for sinusitis based on the PACT Act.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.